Pharmacokinetics of Yimitasvir Phosphate Capsule in Subjects With Normal Renal Function and ESRD

Clinical trial NCT04565171 · COMPLETED

Trial details

NCT number: NCT04565171
Sponsor: Sunshine Lake Pharma Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Renal Impairment

Start date: 2021-04-15
Primary completion: 2022-05-07
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.